Document is current
Any future updates will be listed below
-
Authors
Rutegård, Miriam Kheira https://orcid.org/0000-0003-3510-2165
Båtsman, Malin
Blomqvist, Lennart
Rutegård, Martin
Axelsson, Jan
Wu, Wendy
Ljuslinder, Ingrid
Rutegård, Jörgen
Palmqvist, Richard
Brännström, Fredrik
Riklund, Katrine
-
Funding
Funding for this research was provided by:
Medicinska fakulteten, Umeå Universitet
Cancer Research Foundation in Northern Sweden
- License Information
-
More Information
Article History
Received: 25 June 2024
Revised: 17 November 2024
Accepted: 11 December 2024
First Online: 21 January 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Katrine Riklund.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors, Wendy Wu, a statistician at the Department of Diagnostics and Intervention, Oncology, Umeå University, kindly provided the statistical expertise for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Ethical approval (dnr: 2015/417-31) was obtained from the Regional Ethical Review Board in Umeå, Sweden.
: Nine study subjects (patients) have been previously reported in our published initial findings and method description of the RECTOPET study (NCT03846882) [, ].
:
